Companies / China
Cipla Mulls Chinese Biotech Bid
September 2006 | FDI AlertIndian drugmaker Cipla is reported to be in talks with a number of biotechnology firms in China with the aim of acquiring manufacturing facilities. The company raised US$170mn through global depository receipts in April, which it has earmarked for investment, although no clues to the size of the China investment have been
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
